FDA Drug · D-0037-2027

Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.

Class II · Ongoing

Lack of Assurance of Sterility

Affected lots / codes — check yours against thisLot #: AP-202647, BUD 13-Oct-2026

Recalling firm: Apothecary Pharma LLC, Cary, NC
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 1 vial
Distribution: Nationwide within the United States
Recall initiated: September 24, 2026
Classified: October 8, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0037-2027%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →